Oct. 22nd 10:30-11:05
Inconvenient Truths about Solid Form Landscapes
Susan M. Reutzel-Edens is a Senior Research Advisor in Small Molecule Design & Development at Eli Lilly and Company. She obtained her B.S. degree in chemistry from Winona State University (1987), then earned her Ph.D. in organic chemistry at the University of Minnesota (1991) under the direction of the late Professor Margaret C. Etter. She founded the solid form design program at Eli Lilly and for two decades led a team of cross-functional scientists charged with finding commercially-viable crystalline forms for small-molecule drug products. In this capacity, she has contributed to the development of more than 150 compounds, publishing and presenting her work on key aspects of solid form development, including 1) crystal polymorphism, 2) crystal engineering and materials design, 3) crystal nucleation and growth of small-molecule drug polymorphs and solvates, 4) structure-property relationships in pharmaceutical solids, 5) crystal structure prediction as a complement to experimental solid-state form screening and 6) digital design of drug products. Susan has published over 50 papers and book chapters and is a named inventor on 12 US patents. She was elected Fellow of the Royal Society of Chemistry in 2018, and currently serves as a topic editor for Crystal Growth and Design, and member of both the Editorial Advisory Board of Journal of Pharmaceutical Sciencesand the Scientific Advisory Board of the Cambridge Crystallographic Data Centre. In her current role, she provides strategic oversight of science and technology innovation with a focus on digital product design within the Small Molecule Design & Development organization.